93 related articles for article (PubMed ID: 10692738)
21. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
[TBL] [Abstract][Full Text] [Related]
22. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
Bental B; Tirosh E
J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
[TBL] [Abstract][Full Text] [Related]
23. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
24. Attention-deficit/hyperactivity disorder: an update.
Pary R; Lewis S; Matuschka PR; Lippmann S
South Med J; 2002 Jul; 95(7):743-9. PubMed ID: 12144081
[TBL] [Abstract][Full Text] [Related]
25. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
26. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
Rader R; McCauley L; Callen EC
Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
[TBL] [Abstract][Full Text] [Related]
27. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
28. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
Isaacs D
J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
[TBL] [Abstract][Full Text] [Related]
29. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
DelBello MP
J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
[No Abstract] [Full Text] [Related]
30. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
31. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
Monastra VJ
Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
[TBL] [Abstract][Full Text] [Related]
32. Attention deficit/hyperactivity disorder: complexities and controversies.
Schonwald A; Lechner E
Curr Opin Pediatr; 2006 Apr; 18(2):189-95. PubMed ID: 16601502
[TBL] [Abstract][Full Text] [Related]
33. [The evaluation of the effects of pharmacological treatment of children with attention deficit hyperactivity disorder].
Roselló B; Amado L; Presentación MJ
Rev Neurol; 1999 Feb; 28 Suppl 2():S177-82. PubMed ID: 10778510
[TBL] [Abstract][Full Text] [Related]
34. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
35. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
36. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Fowler JS; Ding YS
Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
[TBL] [Abstract][Full Text] [Related]
37. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
Shmueli D; Gross-Tsur V
Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
[TBL] [Abstract][Full Text] [Related]
38. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
39. [Hyperkinetic syndrome and dyslexia. Medical help for the hyperactive child].
Stiefelhagen P
MMW Fortschr Med; 2002 May; 144(21):4-8. PubMed ID: 12134423
[No Abstract] [Full Text] [Related]
40. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ
J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
